Boston Scientific, IBD Stock Of The Day, Has Surged 57% In 2024. This Is Why There’s More Upside.

Boston Scientific

Boston Scientific

BSX


$0.11



0.12%



67%

IBD Stock Analysis

  • Rebounding from 50-day line within a flat base pattern offering 91.93 entry.

Composite Rating

Industry Group Ranking

Emerging Pattern

Pullback

* Not real-time data. All data shown was captured at
11:48AM EST on
12/26/2024.

Boston Scientific (BSX) is Thursday’s IBD Stock Of The Day as the medtech trades just below all-time highs it hit late last month. Meanwhile, analysts are raising BSX price targets with eyes on 2025.

Boston Scientific stock has gained 57% in 2024 but the average analyst price target sits at 101.06, according to FactSet. That represents a further 11% upside for BSX as it looks to forge a new actionable base.

Morgan Stanley analysts on Dec. 2 wrote that Boston Scientific has a “strong platform of assets it’s pushing and integrating as we move into 2025.”





X



NOW PLAYING
Look For Changes In The Market With These Strategies and Signals



In late October, Boston Scientific reported better-than-expected third-quarter earnings and revenue. Total sales grew 18.2% organically, with overall cardiovascular sales — which includes electrophysiology sales — climbing 25% on a reported basis to $2.73 billion. Medical-surgical sales, Boston Scientific’s other segment, brought in $1.48 billion in sales, climbing 10.3%.

For the year, the company raised its profit outlook to an adjusted $2.45 to $2.47 per share, vs. its prior guidance for $2.38 to $2.42. Boston Scientific also expects full-year sales to grow about 15% organically, above its previous range for 13% to 14% growth.

However, the medtech also announced it paused enrollment in a study of its pulsed field ablation technology.

Pulsed field ablation, also called PFA, uses high-energy electrical pulses to treat abnormal heart rhythm and tumors. Boston Scientific launched its Farapulse PSA system earlier this year. Late last year, the company began the Avant Guard study to test the use of pulsed field ablation as a first treatment for persistent atrial fibrillation. Atrial fibrillation is a heart condition that causes the upper chambers of the heart to beat irregularly. Typically patients receive oral medications.

Analysts view the Farapulse PSA system as major part of analyst optimism on the stock.

Boston Scientific Stock Performance

BSX edged down around 0.15% to 90.93 during market trade on Thursday. The stock bounced of its 50-day moving average last week, putting it in a buy zone.

The stock is also technically in a flat base. But the base is long, dating back to August, the rebound and a high of 91.59 both offer entries before the flat base’s 91.93 entry.

While BSX has surged in 2024, the 126 stocks in the IBD tracked Medical-Products industry group have collectively only advanced 1.5% this year.

Last week, Truist analysts raised their price target on Boston Scientific to 110 from 100 and kept a buy rating on the shares. The firm broadly sees the medical technology sector as “one of the better/safer houses” in health care given its lower “front-line” exposure to health care policy rhetoric that is tied to the White House change of guard.

Earlier this month, TD Cowen raised the firm’s price target on Boston Scientific to 110 from 100 on expectations the company will achieve its goal of being the top-performing large-cap medtech company in 2024-26 and beyond.

Citi also raised its BSX price target 107 from 98 this month. The firm predicts this year’s BSX momentum to continue in 2025 with growth buoyed by the Farapulse pulsed-field ablation and continued adoption and penetration of the company’s “Watchman” left atrial appendage closure device.

Meanwhile, in a Dec. 16 safety communication posted to the site of the Food and Drug Administration, the agency stated alerted “patients, caregivers, and health care providers about the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices, which includes the Accolade, Proponent, Essentio, and Altrua 2 Standard Life and Extended Life pacemakers and the Visionist and Valitude cardiac resynchronization therapy pacemakers.”

“Boston Scientific announced a recall for a subset of Accolade pacemaker devices with an increased risk to permanently enter safety mode, which has limited functionality and has been associated with the pacemaker being unable to properly regulate the heart’s rhythm and rate in some patients,” the notice said.

Boston Scientific stock has a 93 Composite Rating out of a best-possible 99. The stock also has an 88 Relative Strength Rating and a 93 EPS Rating.

Please follow Kit Norton on X @KitNorton for more coverage.

YOU MAY ALSO LIKE:

Is Tesla Stock A Buy Or A Sell?

Get Full Access To IBD Stock Lists And Ratings

Learning How To Pick Great Stocks? Read Investor’s Corner

AI Is Fueling A ‘Nuclear Renaissance.’ Bill Gates And Jeff Bezos Are In The Mix.

The Lithium Price Cycle Has Bottomed. What To Expect Next For These Stocks.



Source link

Visited 1 times, 1 visit(s) today

Related Article

恒指收市跌7點 成交、北水齊創一周高 佑駕創新以最高位收升14% (16:39) – 20241227 – 即時財經新聞

上日內地監管稱擬對銀行業金融機構董事和高管加強管理,內銀股個別發展。佑駕創新(2431)上市,以最高位收,升14.12%,收報19.4元。 恒指今早低開14點,高位升86點,低位跌88點,高低波幅175點。上升股份比例為32.4%,下跌為34.43%,無升跌為33.15%。 恒指收市跌7點或0.04%,報20090點,大市成交金額1395億元,較上日增加64.93%,是12月20日1784.6億元成交後最多;國指升1點或0.02%,報7305點。恒生科技指數收報4538點,升0.69%。 藍籌股成交金額661.42億元,佔大市成交47.41%;科指成份股成交金額462.05億元,佔大市成交33.12%;國指成份股成交金額592.97億元,佔大市成交42.5%。 24隻雙櫃台股,總成交0.56億元人民幣,相當於約0.6億港元,佔大市成交的0.04%。 窩輪及牛熊證成交金額增加8.15%,至63.49億元,佔大市成交4.55%。牛熊證成交金額35.32億元,增加9.49%;窩輪成交金額28.16億元,增加6.5%。 藍籌29隻升,50隻下跌,4隻無升跌。聯想(0992)升9.2%,收報10.56元,是升幅最大的藍籌,中升(0881)跌4.38%,收報14.42元,是跌幅最大的藍籌。 恒生科技指數成份股10隻升,20隻下跌。升幅最大的是聯想(0992)收報10.56元,升9.2%;跌幅最大的是閱文(0772)收報25.9元,跌4.25%。 恒指續高於50天線(20041.18點)。續高於科指10天線(4474.08點)、20天線(4462.26點)、50天線(4469.49點)。 北水南下合計淨流入84.93億元,較上日增加62.48%,淨流入金額是12月19日146.01億元後最多。北水連續第7日流入,累計流入426.45億元,對上一次連續7日淨流入是11月22日。北水本月累計流入816.57億元,按月減少34.68%,金額是9月後新低,連續第18個月流入。 三大指數即日表現 恒指曾跌最多0.44%,是12月19日後最大跌幅,當日跌幅為1.37%。低見20009.95點,是12月24日19908.57點後最低。收市報20090.46點,是12月23日後收市新低,當日報19883.13點。連續第5日陽燭,對上一次連續第5日陽燭是9月16日。 科指曾升最多1.56%,是12月24日後最大升幅,當日升幅為1.59%。高見4578.15點,是12月12日4659.95點後最高。收市報4538.59點,是12月12日後收市新高,當日報4600.82點。連升4日,累計升99.12點,對上一次連升4日是11月20日。連續第2日陽燭,對上一次連續第2日陽燭是12月18日。 國指曾升最多0.54%,是12月24日後最大升幅,當日升幅為1.64%。高見7343.17點,是12月12日7415.37點後最高。收市報7305.36點,是12月12日後收市新高,當日報7360.1點。連升3日,累計升161.48點,對上一次連升3日是12月3日。連續第7日陽燭,對上一次連續第7日陽燭是9月19日。 一周表現 恒指本周累升1.87%或369點,升幅是12月06日後最大,當時收市升幅為2.28%;本周表現最佳的是東方海外(0316),累升13.22%,其次為聯想(0992)及比亞迪電子(0285),分別升11.51%及10.73%。而表現最差的是海底撈(6862),累跌3.64%,其次為中升(0881)及華潤電力(0836),分別跌2.83%及2.81%。 國指本周累升2.26%或161點,升幅是12月06日後最大,當時收市升幅為2.73%;本周表現最佳的是聯想(0992),累升11.51%,其次為中芯國際(0981)及小米(1810),分別升8.3%及7.9%。而表現最差的是海底撈(6862),累跌3.64%,其次為美團(3690)及吉利(0175),分別跌2.46%及2.35%。 科指本周累升2.12%或94點,升幅是12月06日後最大,當時收市升幅為2.55%;本周表現最佳的是聯想(0992),累升11.51%,其次為比亞迪電子(0285)及中芯國際(0981),分別升10.73%及8.3%。而表現最差的是閱文(0772),累跌5.13%,其次為美團(3690)及金蝶(0268),分別跌2.46%及2.44%。 午後消息股表現 小米(1810)料今年手機銷量升43% 下一步突破6000元以上價格手機。小米創52周高,見34.95元,收報34.15元,升4.27%。 電動車減價戰升溫 比亞迪增車款優惠減12%加補貼。汽車股 吉利(0175)收報14.96元,跌2.48%。 比亞迪(1211)收報273.6元,跌0.07%。 小鵬(9868)收報49.35元,跌1.5%。 理想(2015)收報100.4元,升6.13%。 蔚來(9866)收報36.4元,升3.41%。 零跑(9863)收報33.9元,升3.51%。 今早及隔晚消息股表現   內地監管稱擬對銀行業金融機構董事和高管加強管理 內銀股 建行(0939)創52周高,見6.52元,收報6.47元,跌0.31%。 農行(1288)創52周高,見4.45元,收報4.41元,升0.46%。 工行(1398)創52周高,見5.2元,收報5.16元,升0.19%。 郵儲行(1658)收報4.49元,跌3.85%。 交行(3328)創52周高,見6.36元,收報6.32元,升0.8%。 招行(3968)收報39.65元,跌0.13%。 中行(3988)創52周高,見3.99元,收報3.94元,跌0.51%。 格里拉首間柬埔寨酒店明開業。香格里拉(0069)收報5.31元,升0.95%。 佑駕創新(2431)今日上市,定價17元。創上市新高,見19.4元,創上市新低,見17.64元,收報19.4元,升14.12%。 S&T HLDGS(3928)最快今日公布業績。收報2.4元,跌9.77%。 小米(1810)據報正搭建GPU萬卡集群,大力投入AI大模型。創52周高,見34.95元,收報34.15元,升4.27%。 阿里巴巴(9988)據報擬將韓國業務與易買得合併,交易估值40億美元。收報82.35元,跌0.96%。 京東(9618)逾2萬名客服獲加人工,平均加薪2個月。收報135.9元,跌3.55%。 藥明康德(2359)擬售WuXi ATU英、美業務,佔營業收入2.4%。收報53.9元,跌3.14%。 TCL電子(1070)售巴西空調業務套現逾2.77億元。收報6.22元,升0.16%。 天瑞(1252)先舊後新配售集資4700萬,九成用於還債。收報0.325元,跌5.8%。 新特能源(1799)撤回A股上市及暫停10萬噸項目。收報7.46元,跌4.11%。 中匯集團(0382)旗下華商職業學院4.38億建新會校園。收報2.14元,無升跌。 亞博科技(8279)出資3500萬向螞蟻銀行(澳門)增資。收報0.201元,跌0.99%。 太地(1972)連續8年獲納入道瓊斯可持續發展世界指數。收報15.94元,升0.25%。

Eddid Financial Partners with HKBU for the Third Consecutive Year to Establish 10th Anniversary Scholarship

HONG KONG, Dec. 27, 2024 /PRNewswire/ — Building on successful collaborations with the School of Oriental and African Studies (“SOAS”) at the University of London, Hong Kong University of Science and Technology, The Hong Kong Polytechnic University, and City University of Hong Kong, Eddid Financial (the “Group”) announces its partnership with Hong Kong Baptist University

恒指半日升23點 科指升1.2% 佑駕創新升10% (12:11) – 20241227 – 即時財經新聞

恒指今早低開14點,高位升86點,低位跌88點,高低波幅175點。上升股份比例為24.97%,下跌為30.44%,無升跌為44.58%。 恒指半日升23點或0.12%,報20121點,大市成交金額856億元;國指升12點或0.17%,報7316點。恒生科技指數收報4561點,升1.2%。 藍籌股成交金額400.03億元,佔大市成交46.73%;科指成份股成交金額303.15億元,佔大市成交35.41%;國指成份股成交金額366.76億元,佔大市成交42.84%。 24隻雙櫃台股,總成交0.38億元人民幣,相當於約0.41億港元,佔大市成交的0.05%。 窩輪及牛熊證成交金額減少4.14%,至56.27億元,佔大市成交6.57%。牛熊證成交金額30.42億元,減少5.68%;窩輪成交金額25.84億元,減少2.28%。 藍籌31隻升,44隻下跌,8隻無升跌。理想(2015)升7.4%,收報101.6元,是升幅最大的藍籌,農夫山泉(9633)跌4.25%,收報33.8元,是跌幅最大的藍籌。 恒生科技指數成份股14隻升,14隻下跌,2隻無升跌。升幅最大的是理想(2015)收報101.6元,升7.4%;跌幅最大的是閱文(0772)收報25.95元,跌4.07%。 恒指續高於50天線(20041.81點)。科指續高於10天線(4476.39點)。 北水南下合計淨流入48.88億元,較上日減少6.49%,連續第7日流入,累計流入390.39億元,對上一次連續7日淨流入是11月22日。北水本月累計流入780.52億元,按月減少37.57%,金額是9月後新低,連續第18個月流入。 佑駕創新(2431)今日上市,定價17元。創上市新高,見18.88元,收報18.7元,升10%。 S&T HLDGS(3928)最快今日公布業績。收報2.45元,跌7.89%。 小米(1810)據報正搭建GPU萬卡集群,大力投入AI大模型。創52周高,見34.95元,收報34.55元,升5.5%。 阿里巴巴(9988)據報擬將韓國業務與易買得合併,交易估值40億美元。收報82.35元,跌0.96%。 京東(9618)逾2萬名客服獲加人工,平均加薪2個月。收報135.7元,跌3.69%。 藥明康德(2359)擬售WuXi ATU英、美業務,佔營業收入2.4%。收報54.15元,跌2.7%。 TCL電子(1070)售巴西空調業務套現逾2.77億元。收報6.19元,跌0.32%。 天瑞(1252)先舊後新配售集資4700萬,九成用於還債。收報0.325元,跌5.8%。 新特能源(1799)撤回A股上市及暫停10萬噸項目。收報7.47元,跌3.98%。 中匯集團(0382)旗下華商職業學院4.38億建新會校園。收報2.15元,升0.47%。 亞博科技(8279)出資3500萬向螞蟻銀行(澳門)增資。收報0.201元,跌0.99%。 太地(1972)連續8年獲納入道瓊斯可持續發展世界指數。收報16.08元,升1.13%。 中移動(0941)子公司與埃及電訊達成策略商業協議,發展海底基建及企業方案。收報76.15元,升0.13%。 華潤醫藥(3320)子公司推第三代缺血性中風溶栓劑。收報5.63元,升1.26%。 香港寬頻(1310)簽署52.5億元可持續發展掛鈎貸款協議。收報5.13元,升0.79%。 中銀(2388)牽頭先正達45億美元銀團,為今年亞太最大宗可持續表現掛鈎貸款。收報24.95元,跌0.99%。 中渝置地(1224):委任張松橋女兒張渝翎為執董。收報1.18元,無升跌。 破頂股表現 破頂股包括,新華文軒(0811)創上市新高,見11.82元,收報11.8元,升1.03%;安徽皖通高速公路(0995)創上市新高,見10.34元,收報10.26元,升0.39%;高偉電子(1415)創上市新高,見29.6元,收報28.75元,跌0.86%;康耐特光學(2276)創上市新高,見23.25元,收報22.3元,升6.95%;一脈陽光(2522)創上市新高,見67.3元,收報66.95元,升5.1%;金山雲(3896)創上市新高,見6.7元,收報6.19元,升33.69%;小米集團-WR(81810)創上市新高,見32.75元,收報32.45元,升4.85%;佑駕創新(2431)創上市新高,見18.88元,升10%;越疆科技(2432)創上市新高,見24.05元,收報23.85元,升23.96%;A工銀中金美(3011)創上市新高,見9040.55元,收報9040.4元,無升跌;A南方港元(3053)創上市新高,見1142.6元,收報1142.6元,升0.01%;AGX美元(3137)創上市新高,見1050.15元,收報1050.15元,升0.01%;A工銀中金美-U(9011)創上市新高,見1164.3元,收報1164.3元,升0.05%;比亞迪電子(0285)創52周高,見43.6元,收報43.2元,升3.47%。 破頂指數成份股包括,小米(1810)創52周高,見34.95元,收報34.55元,升5.5%;比亞迪電子(0285)創52周高,見43.6元,收報43.2元,升3.47%;工行(1398)創52周高,見5.2元,收報5.15元,無升跌;中國銀行(3988)創52周高,見3.99元,收報3.94元,跌0.51%;匯控(0005)創52周高,見75.55元,收報75.35元,升0.6%;建行(0939)創52周高,見6.52元,收報6.45元,跌0.62%;農業銀行(1288)創52周高,見4.45元,收報4.39元,無升跌;交行(3328)創52周高,見6.35元,收報6.34元,升1.12%。 破底股方面 20隻股份創上市新低,其中十隻包括,ALCO HOLDINGS(0328)低見0.435元,收報0.45元,跌6.25%;新宇環保(0436)低見0.042元,收報0.042元,跌17.65%;瑞浦蘭鈞(0666)低見11.5元,收報11.6元,跌1.36%;中國衛生集團(0673)低見0.25元,收報0.365元,跌47.86%;知行汽車科技(1274)低見14.8元,收報15元,跌3.6%;銳信控股(1399)低見0.175元,收報0.176元,跌2.76%;力高集團(1622)低見0.199元,收報0.208元,跌1.89%;金石控股集團(1943)低見0.067元,收報0.067元,跌4.29%;眾誠能源(2337)低見1.55元,收報1.58元,跌1.86%;友寶在線(2429)低見3.51元,收報3.57元,無升跌。 創52周低,包括,漢國置業(0160)低見1.06元,收報1.06元,跌1.85%;協合新能源(0182)低見0.51元,收報0.52元,升1.96%;和記電訊香港(0215)低見0.92元,收報0.93元,升1.09%;建業實業(0216)低見0.64元,收報0.64元,跌3.03%;CEC INT’L HOLD(0759)低見0.121元,收報0.121元,跌6.92%;中國創新投資(1217)低見0.01元,收報0.01元,跌9.09%;易大宗(1733)低見1.25元,收報1.27元,跌0.78%;完美醫療(1830)低見2.19元,收報2.2元,跌0.9%;東曜藥業-B(1875)低見1.48元,收報1.58元,跌1.25%。 異動股 上升異動股,包括,神通機器人教育(8206)創52周高,見0.08元,收報0.063元,升40%;金山雲(3896)創上市新高,見6.7元,收報6.19元,升33.69%;量子思維(8050)收報0.29元,升31.82%;世大控股(8003)收報0.121元,升31.52%;和鉑醫藥-B(2142)收報1.85元,升29.37%;中港石油(0632)收報0.56元,升27.27%;博駿教育(1758)收報0.148元,升25.42%;越疆科技(2432)創上市新高,見24.05元,收報23.85元,升23.96%;懶豬科技(8379)收報0.088元,升23.94%;新都酒店(8315)創上市新低,見0.04元,收報0.059元,升22.92%;靖洋集團(8257)收報0.1元,升21.95%。 下跌異動股,包括,中國衛生集團(0673)創上市新低,見0.25元,收報0.365元,跌47.86%;中國三三傳媒(8087)收報0.335元,跌25.56%;九台農商銀行(6122)創上市新低,見0.495元,收報0.51元,跌22.73%;能源及能量環球(1142)收報0.51元,跌20.31%;環能國際(1102)收報0.068元,跌18.07%;中顯智能齊家控股(8395)見52周低0.33元,收報0.395元,跌17.71%;新宇環保(0436)創上市新低,見0.042元,收報0.042元,跌17.65%;中國集成控股(1027)收報1.1元,跌17.29%;沿海家園(1124)收報0.134元,跌16.25%;高維科技(2086)收報0.415元,跌15.31%;國茂控股(8428)收報0.415元,跌14.43%。 其他報道 滬深三大指數半日向上 滬指企穩3400點 港元拆息普遍向上 1個月HIBOR、港元升值 創兩個月高、最強 貨幣總結餘上升 香格里拉首間柬埔寨酒店明開業 嘉禾V Walk宣布暫停營業 內地11月規模以上工業企業利潤跌7.3% 連跌4個月 滬深三大指數近平開 人行淨投放62億人幣 恒指低開14點

恒指低開14點 科指升0.3% 佑駕創新上市升9.4% (09:26) – 20241227 – 即時財經新聞

藍籌20隻升,41隻下跌,22隻無升跌。理想(2015)升3.59%,報98元,是升幅最大的藍籌,海爾智家(6690)跌2.88%,報27元,是跌幅最大的藍籌。 恒生科技指數成份股16隻升,12隻下跌,2隻無升跌。升幅最大的是理想(2015)開市報98元,升3.59%;跌幅最大的是海爾智家(6690)開市報27元,跌2.88%。 恒指續高於50天線(20041.04點)。科指續高於10天線(4472.72點)。 佑駕創新(2431)今日上市,定價17元。開報18.6元,升9.4%。 S&T HLDGS(3928)最快今日公布業績。無成交,報2.66元。 小米(1810)據報正搭建GPU萬卡集群,大力投入AI大模型。創52周高,見33.5元,開市報33.5元,升2.29%。 阿里巴巴(9988)據報擬將韓國業務與易買得合併,交易估值40億美元。開市報83元,跌0.18%。 京東(9618)逾2萬名客服獲加人工,平均加薪2個月。開市報138.7元,跌1.56%。 藥明康德(2359)擬售WuXi ATU英、美業務,佔營業收入2.4%。開市報55.25元,跌0.72%。 TCL電子(1070)售巴西空調業務套現逾2.77億元。開市報6.21元,無升跌。 天瑞(1252)先舊後新配售集資4700萬,九成用於還債。開市報0.335元,跌2.9%。 新特能源(1799)撤回A股上市及暫停10萬噸項目。開市報7.73元,跌0.64%。 中匯集團(0382)旗下華商職業學院4.38億建新會校園。無成交,報2.14元。 亞博科技(8279)出資3500萬向螞蟻銀行(澳門)增資。無成交,報0.203元。 太地(1972)連續8年獲納入道瓊斯可持續發展世界指數。開市報15.9元,無升跌。 中移動(0941)子公司與埃及電訊達成策略商業協議,發展海底基建及企業方案。開市報75.6元,跌0.59%。 華潤醫藥(3320)子公司推第三代缺血性中風溶栓劑。開市報5.56元,無升跌。 香港寬頻(1310)簽署52.5億元可持續發展掛鈎貸款協議。開市報5.1元,升0.2%。 中銀(2388)牽頭先正達45億美元銀團,為今年亞太最大宗可持續表現掛鈎貸款。開市報25.2元,無升跌。 中渝置地(1224):委任張松橋女兒張渝翎為執董。無成交,報1.18元。 破頂股表現 破頂股包括,小米集團-WR(81810)創上市新高,見31元,開市報31元,升0.16%;小米(1810)創52周高,見33.5元,開市報33.5元,升2.29%;匯控(0005)創52周高,見75.5元,開市報75.5元,升0.8%;農業銀行(1288)創52周高,見4.45元,開市報4.45元,升1.37%;匯豐控股(0005)創52周高,見75.5元,開市報75.5元,升0.8%;小米集團-W(1810)創52周高,見33.5元,開市報33.5元,升2.29%;微盟集團(2013)創52周高,見3.4元,開市報3.4元,升4.62%。 破頂指數成份股包括,小米(1810)創52周高,見33.5元,開市報33.5元,升2.29%;匯控(0005)創52周高,見75.5元,開市報75.5元,升0.8%;農業銀行(1288)創52周高,見4.45元,開市報4.45元,升1.37%。 破底股方面 創上市新低,包括FI二南方日經(7515)低見60元,開市報60元,跌3.54%。 創52周低,其中包括,建業實業(0216)低見0.64元,開市報0.64元,跌3.03%;易大宗(1733)低見1.27元,開市報1.27元,跌0.78%。 異動股 上升異動股,包括,烯石電車新材料(6128)開市報0.046元,升15%;弘浩國際控股(8375)開市報2.78元,升14.88%;億都(國際控股)(0259)開市報3.02元,升14.83%;量子思維(8050)開市報0.25元,升13.64%;朗華國際集團(8026)開市報0.345元,升13.11%;金山雲(3896)開市報5.19元,升12.1%;中興通訊(0763)開市報24.15元,升9.77%;光啟科學(0439)開市報1.98元,升8.2%;志道國際(1220)開市報0.095元,升7.95%;速騰聚創(2498)開市報31.4元,升7.9%;WMCH GLOBAL(8208)開市報0.031元,升6.9%。 下跌異動股,包括,九台農商銀行(6122)開市報0.61元,跌7.58%;華新手袋國際控股(2683)開市報0.5元,跌5.66%;世界(集團)(0713)開市報0.59元,跌4.84%;達芙妮國際(0210)開市報0.237元,跌4.44%;恩典生命科技(2112)開市報0.112元,跌4.27%;澳優(1717)開市報1.91元,跌4.02%;中食民安(8283)開市報0.048元,跌4%;FI二南方日經(7515)創上市新低,見60元,開市報60元,跌3.54%;智欣集團控股(2187)開市報0.6元,跌3.23%。 其他報道 港股ADR升105點 夜期低水174點 佑駕創新上市 美債息回軟 道指升28點 連升5日創一周高 Source link

內地11月規模以上工業企業利潤跌7.3% 連跌4個月 (09:50) – 20241227 – 即時財經新聞

11月末,規模以上工業企業每百元資產實現的營業收入為77.7元,年減2.9元;產成品存貨周轉天數為19.8天,較去年同期增加0.1天;應收帳款平均回收期為66.7天,較去年同期增加4.2天。規模以上工業企業應收帳款26.92兆元,較去年增長8.5%;產成品存貨6.57兆元,增長3.3%。 國統局工業司統計師於衛寧解讀指,雖然規模以上工業企業利潤仍處下降區間,但隨著政策組合效應持續顯現,工業企業利潤降幅繼續收窄,效益狀況改善。 報告內容如下: 11月份,隨著存量政策有效落實,一攬子增量政策加快推出,政策組合效應持續發揮,帶動規模以上工業生產平穩增長,企業效益持續恢復。當月工業企業營業收入由降轉增,利潤降幅持續收窄,製造業高端化、智慧化、綠色化深入推進。企業效益狀況呈現以下特色: 工業企業當月營業收入由降轉增加。隨著政策效應持續釋放,規模以上工業生產加快,帶動企業當月營業收入由降轉增。 11月份,全國規模以上工業企業營業收入年增0.5%,上月為下降0.2%,當月營業收入連續兩個月回升。 1—11月份,規上工業企業累計營業收入維持增長,較去年同期增長1.8%。 工業企業當月獲利降幅持續縮小。 11月份,全國規模以上工業企業獲利年減7.3%,在去年高基數基礎上降幅較10月份收窄2.7個百分點。其中,受價格回升、收入轉增帶動,工業企業獲利空間改善,反映企業效益基本面狀況的毛利降幅連續兩個月收窄。三大門類中,採礦業利潤降幅較10月份收窄10.9個百分點,製造業降幅收窄0.3個百分點;電力、熱力、燃氣及水生產及供應業利潤當月增長4.8%,較10月份加快0.3個百分點。 1—11月份,規上工業企業累計利潤總額達6.67兆元,較去年同期下降4.7%。 製造業高端化、智慧化、綠色化深入推進。 11月份,製造業高端化、智慧化、綠化相關產業利潤快速增長,為工業高品質發展提供穩定支撐。其中,高端裝備製造業利潤增長較快,光電子元件製造、航太相關設備製造等產業利潤較去年同期分別增長41.1%、14.3%;智慧化、自動化產品生產加速帶動相關產業利潤增加,穿戴式智慧型裝置製造、繪圖計算及測量儀器製造等產業利潤分別增長90.3%、31.3%;綠色生產、綠色生活方式加速形成,推動相關產業利潤增長向好,鋰離子電池製造、環境監測專用儀器儀表製造等產業利潤分別增長35.3%、 17.9%。 「兩新」政策持續落實。 11月份,隨著各項政策工具綜合運用,「兩新」政策效能持續顯現,相關產業利潤快速增長。在大規模設備更新相關政策帶動下,專用設備製造業利潤年增36.7%。其中,電子和電工機械專用設備製造,採礦、冶金、建築專用設備製造,化學、木材、非金屬加工專用設備製造等產業利潤快速增長,較去年同期分別增長110.6%、90.4%、35.7%。家電、家裝、廚衛等消費品領域以舊換新政策落實,相關產業利潤增長較快。其中,家用清潔衛生電器製造、家用冷凍電器製造、耐火陶瓷製品及其他耐火材料製造、家用空氣調節器製造等產業利潤分別增長311.4%、82.9%、25.0%、11.1%。 消費品製造業利潤較快增長。隨著宏觀政策發力顯效,工業品出口持續增加,11月份消費品製造業利潤較去年同期增長22.0%,拉動全部規上工業利潤增長3.7個百分點。從產業來看,消費品製造業的13個產業中有8個產業獲利年增,其中,受部分企業投資收益到帳等短期因素影響,酒飲料茶業獲利年增292.3%;此外,化纖、文教職員美、紡織服裝等產業利潤均維持較快增長,年比分別增長16.3%、14.7%、8.2%。 整體看,雖然規模以上工業企業利潤仍處下降區間,但隨著政策組合效應持續顯現,工業企業利潤降幅繼續收窄,效益狀況改善。下階段,要深入貫徹中央經濟工作會議精神,繼續抓好各項政策落實落細,不斷增強發展新動能,推動工業經濟持續鞏固回升。 其他報道 滬深三大指數近平開 人行淨投放62億人幣 恒指低開14點 科指升0.3% 佑駕創新上市升9.4% 東京12月通脹連續第二個月加速 日圓升值見一周高 港股ADR升105點 夜期低水174點 佑駕創新上市 美債息回軟 道指升28點 連升5日創一周高 Source link

Dow ends up to extend win run to five; rising yields pressure megacap stocks By Reuters

By David French (Reuters) -The closed fractionally higher on Thursday, stretching its winning streak to five sessions despite light trading volumes and rising U.S. Treasury yields weighing on some of the dominant technology megacaps. While the and the were broadly unchanged, the indexes both finished slightly in negative territory. This snapped the Nasdaq’s four-session run

Why Stock Splits Might Be Ahead

A stock split has no fundamental impact on a business’s health but it is a sign of business health investors should heed. Data from Bank of America shows that companies that split their stock tend to outperform the broad market and deliver leveraged returns over time.  Companies split stocks because their share prices are rising

Apple stock touches intraday high after nod of confidence from Wall Street

Apple (AAPL) stock hit an all-time intraday high Thursday after a nod of confidence in its continued upswing from Wall Street. Wedbush analyst Dan Ives raised his price target on Apple shares to a new Street high of $325, anticipating “a golden era of growth” for the Tim Cook-helmed tech giant in 2025. “We believe

2 Stocks to Buy Hand Over Fist Before the Nasdaq Soars Higher in 2025

Technology stocks have been in scintillating form on the market in the past couple of years, which is evident from the 86% gains clocked by the Nasdaq Composite index during this period, and the good news is that the impressive run in tech stocks could continue in 2025 as well. Historical trends show that the

How the stock market defied expectations again this year, by the numbers

NEW YORK (AP) — What a wonderful year 2024 has been for investors. U.S. stocks ripped higher and carried the S&P 500 (^GSPC) to records as the economy kept growing and the Federal Reserve began cutting interest rates. The year featured many familiar winners, such as Big Tech, which got even bigger as their stock

India roars ahead of China to top Asian IPO rankings

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. India has eclipsed China as Asia’s top market for company listings this year, as buoyant stock prices spark a boom in initial public offerings. Propelled by companies including Swiggy and Hyundai Motor, India will be

Is Nvidia (NVDA) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock’s price, but are they really important? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let’s see

JPMorgan Says These 2 Value Stocks Are Among Its ‘Best Idea’ Picks for 2025

With just one week left of 2024, the markets are riding high. The S&P 500 is up over 25% for the year, and most analysts are expecting further gains in 2025. Watching the situation, JPM’s chief US equity strategist Dubravko Lakos-Bujas has noted several factors buttressing the US markets. “US equities should remain supported by

NVIDIA’s Hidden Gem. How AI Will Redefine Its Stock Value!

In the rapidly evolving landscape of technology, NVIDIA stands out not just for its groundbreaking graphics processing units (GPUs) but increasingly for its pivotal role in artificial intelligence innovation. As the AI sector balloons, NVIDIA is strategically positioned to capture even more of the market share, potentially pushing its stock beyond just tech enthusiasts’ expectations.

The Best High-Yield Dividend ETF to Invest $2,000 in Right Now

Looking for a high-yield ETF to boost your income in the long run? It’s never too early to start planning your nest egg’s dividend payouts, and this recently introduced ETF could be just what you need. High-yield funds can be risky. In a perfect world, every ultra-generous dividend yield would be a direct result of

4 Dividend Stocks to Double Up on Right Now

You can pat yourself on the back if you’re thinking of loading up your portfolio with dividend-paying stocks — because they’re surprisingly strong wealth builders. (If you weren’t thinking of doing so, you can start now!) Dividend payers aren’t slouches. They’re not sleepy stocks only suitable for grandparents. Plenty of high-performing growth stocks pay dividends

0
Would love your thoughts, please comment.x
()
x